A detailed history of Plancorp, LLC transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Plancorp, LLC holds 10,085 shares of BMY stock, worth $597,737. This represents 0.02% of its overall portfolio holdings.

Number of Shares
10,085
Previous 9,607 4.98%
Holding current value
$597,737
Previous $398,000 30.9%
% of portfolio
0.02%
Previous 0.02%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

BUY
$39.66 - $51.75 $18,957 - $24,736
478 Added 4.98%
10,085 $521,000
Q2 2024

Aug 09, 2024

BUY
$40.25 - $52.99 $5,071 - $6,676
126 Added 1.33%
9,607 $398,000
Q1 2024

May 14, 2024

BUY
$47.98 - $54.4 $5,229 - $5,929
109 Added 1.16%
9,481 $514,000
Q4 2023

Feb 09, 2024

SELL
$48.48 - $57.85 $3,732 - $4,454
-77 Reduced 0.81%
9,372 $480,000
Q3 2023

Nov 08, 2023

BUY
$57.89 - $64.73 $27,555 - $30,811
476 Added 5.3%
9,449 $548,000
Q2 2023

Jul 26, 2023

BUY
$63.71 - $70.74 $17,520 - $19,453
275 Added 3.16%
8,973 $573,000
Q1 2023

May 11, 2023

BUY
$65.71 - $74.53 $2,496 - $2,832
38 Added 0.44%
8,698 $602,000
Q4 2022

Feb 14, 2023

BUY
$68.48 - $81.09 $6,711 - $7,946
98 Added 1.14%
8,660 $623,000
Q3 2022

Nov 10, 2022

SELL
$0.13 - $76.84 $42 - $25,357
-330 Reduced 3.71%
8,562 $609,000
Q2 2022

Aug 04, 2022

BUY
$72.62 - $79.98 $32,533 - $35,831
448 Added 5.31%
8,892 $685,000
Q1 2022

May 13, 2022

BUY
$61.48 - $73.72 $24,899 - $29,856
405 Added 5.04%
8,444 $617,000
Q4 2021

Feb 11, 2022

SELL
$53.63 - $62.52 $21,130 - $24,632
-394 Reduced 4.67%
8,039 $501,000
Q3 2021

Nov 15, 2021

BUY
$59.17 - $69.31 $31,064 - $36,387
525 Added 6.64%
8,433 $499,000
Q2 2021

Aug 13, 2021

SELL
$61.91 - $67.42 $128,772 - $140,233
-2,080 Reduced 20.82%
7,908 $528,000
Q1 2021

May 14, 2021

SELL
$59.34 - $66.74 $51,744 - $58,197
-872 Reduced 8.03%
9,988 $631,000
Q4 2020

Feb 09, 2021

BUY
$57.74 - $65.43 $39,494 - $44,754
684 Added 6.72%
10,860 $674,000
Q3 2020

Nov 16, 2020

BUY
$57.43 - $63.64 $5,398 - $5,982
94 Added 0.93%
10,176 $614,000
Q2 2020

Aug 11, 2020

SELL
$54.82 - $64.09 $35,194 - $41,145
-642 Reduced 5.99%
10,082 $593,000
Q1 2020

May 14, 2020

BUY
$46.4 - $67.43 $26,772 - $38,907
577 Added 5.69%
10,724 $598,000
Q4 2019

Feb 03, 2020

BUY
$49.21 - $64.19 $213,866 - $278,969
4,346 Added 74.92%
10,147 $651,000
Q3 2019

Nov 12, 2019

SELL
$42.77 - $50.71 $1,283 - $1,521
-30 Reduced 0.51%
5,801 $294,000
Q2 2019

Aug 13, 2019

SELL
$44.62 - $49.34 $30,341 - $33,551
-680 Reduced 10.44%
5,831 $264,000
Q1 2019

May 14, 2019

BUY
$45.12 - $53.8 $45,029 - $53,692
998 Added 18.1%
6,511 $311,000
Q4 2018

Feb 14, 2019

SELL
$48.76 - $63.23 $69,483 - $90,102
-1,425 Reduced 20.54%
5,513 $287,000
Q3 2018

Nov 13, 2018

BUY
$55.19 - $62.25 $24,228 - $27,327
439 Added 6.75%
6,938 $431,000
Q2 2018

Aug 14, 2018

BUY
$50.53 - $62.98 $151 - $188
3 Added 0.05%
6,499 $360,000
Q1 2018

Apr 16, 2018

BUY
$59.92 - $68.98 $42,722 - $49,182
713 Added 12.33%
6,496 $412,000
Q4 2017

Jan 19, 2018

BUY
$59.94 - $65.35 $17,922 - $19,539
299 Added 5.45%
5,783 $353,000
Q3 2017

Oct 11, 2017

BUY
$55.23 - $63.74 $302,881 - $349,550
5,484
5,484 $351,000

Others Institutions Holding BMY

About BRISTOL MYERS SQUIBB CO


  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $126B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Plancorp, LLC Portfolio

Follow Plancorp, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Plancorp, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Plancorp, LLC with notifications on news.